Orchestra BioMed
(NASDAQ) OBIO
Orchestra BioMed Financials at a Glance
Market Cap
$272.71M
Revenue (TTM)
$33.48M
Net Income (TTM)
$52.70M
EPS (TTM)
$-1.29
P/E Ratio
-3.62
Dividend
$0.00
Beta (Volatility)
0.90 (Low)
Dividend
$0.00
Beta (Volatility)
0.90 (Low)
Price
$4.58
Volume
2,881
Open
$4.77
Price
$4.58
Volume
2,881
Open
$4.77
Previous Close
$4.58
Daily Range
$4.58 - $4.81
52-Week Range
$2.20 - $5.42
Dividend
$0.00
Beta (Volatility)
0.90 (Low)
Price
$4.58
Volume
2,881
Open
$4.77
Previous Close
$4.58
Daily Range
$4.58 - $4.81
52-Week Range
$2.20 - $5.42
OBIO News
OBIO: Motley Fool Moneyball Superscore
Our CEO Is Handing Members His Secret Weapon
It's called Motley Fool Moneyball, our new proprietary AI tool
We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.
Get Access NowAbout Orchestra BioMed
Industry
Healthcare Equipment and Supplies
Sector
Health CareEmployees
86
CEO
David P. Hochman
Website
www.orchestrabiomed.comHeadquarters
New Hope, PA 18938, US
OBIO Financials
Key Financial Metrics (TTM)
Gross Margin
99%
Operating Margin
-2%
Net Income Margin
-2%
Return on Equity
-109%
Return on Capital
-53%
Return on Assets
-46%
Earnings Yield
-27.62%
Dividend Yield
0.00%
Payout Ratio
0.00%
Stock Overview
Market Cap
$272.71M
Shares Outstanding
58.52M
Volume
2.88K
Short Interest
0.00%
Avg. Volume
220.79K
Financials (TTM)
Gross Profit
$33.29M
Operating Income
$51.81M
EBITDA
$51.48M
Operating Cash Flow
$48.96M
Capital Expenditure
$489.00K
Free Cash Flow
$49.45M
Cash & ST Invst.
$106.51M
Total Debt
$1.69M
Orchestra BioMed Performance Analysis
Revenue Growth Rate
Annual and quarterly growth comparisonEarnings Per Share Growth Rate
Annual and quarterly EPS growth comparisonQuarterly Performance
Revenue
$30.92M
+12120.2%
Gross Profit
$30.87M
+15728.7%
Gross Margin
99.84%
N/A
Market Cap
$272.71M
N/A
Market Cap/Employee
$3.90M
N/A
Employees
70
N/A
Net Income
$6.25M
+138.7%
EBITDA
$6.84M
+141.2%
Quarterly Fundamentals
Net Cash
$74.08M
+47.3%
Accounts Receivable
$95.00K
+3.3%
Inventory
$310.00K
+79.2%
Long Term Debt
$31.69M
+98.3%
Short Term Debt
$751.00K
+36.5%
Return on Assets
-45.88%
N/A
Return on Invested Capital
-52.80%
N/A
Free Cash Flow
$2.30M
+83.1%
Operating Cash Flow
$2.27M
+83.2%